Plasma p-tau217 Blood Test Identified Alzheimer’s Pathology in Meta-Analysis

Plasma p-tau217 Blood Test Identified Alzheimer's Pathology in Meta-Analysis

TL;DR: A 2026 systematic review and meta-analysis in Molecular Neurobiology found that plasma phosphorylated tau 217 (p-tau217), a blood marker of Alzheimer-linked tau pathology, identified biomarker-defined Alzheimer’s disease with pooled sensitivity of 85.4% and specificity of 88.0% across 27 studies. Key Findings 27-study evidence base: Researchers analyzed 19,652 participants from studies that compared plasma p-tau217 …

Read more

Plasma p-tau217 Blood Test Predicts Alzheimer’s Symptom Onset within 3 Years (2026 Research)

TL;DR: A 2026 study in Nature Medicine showed plasma p-tau217 could help estimate when cognitively normal people with Alzheimer’s pathology would develop symptoms, with prediction errors around 3.0 to 3.7 years. Key Findings 3.0-3.7 year prediction window: The p-tau217 blood test estimates when cognitively unimpaired individuals will develop symptomatic Alzheimer’s disease with a median absolute …

Read more